BGMBGM Group Ltd.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · bgmgroupltd.com

0.2623USD-0.38%Mkt Cap: 105.08M $P/E: —3d ago

BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. The company operates through Diversified Pharmaceutical and Allied Products; AI Solution; and Insurance Business segme…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.19BUSDP/E 23.7

TAK

Takeda Pharmaceutical Co. Ltd.

$58.06BUSD

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$43.98BUSDP/E 20.4

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

Neurocrine Biosciences, Inc.

$15.51BUSDP/E 22.3

ELAN

Elanco Animal Health Incorporat

$11.98BUSD

RDY

Dr. Reddy's Laboratories Ltd

Hims & Hers Health, Inc.

$7.88BUSD

LNTH

Lantheus Holdings Inc

$6.53BUSDP/E 23.9

AMRX

Amneal Pharmaceuticals, Inc. Class A

Kiniksa Pharmaceuticals, Ltd.

$6.08BUSDP/E 79.8

Key Statistics

Company

Market Cap105.08M $

Enterprise Value44.77M $

Revenue (TTM)37.92M $

Gross Profit6.31M $

Net Income (TTM)-19.94M $

Revenue/Share0.3350 USD

Last Price0.2623 USD

Fiscal Year EndSep 2025

MR QuarterSep 2025

Employees—

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-4.03

EV/Revenue1.18

P/S2.77

P/B0.13

EPS (TTM)-0.18

EPS (Forward)—

52W Range

0.252338% of range0.2783

52W High0.2783 USD

52W Low0.2523 USD

Profitability

Gross Margin16.64%

Oper. Margin-43.81%

EBITDA Margin-29.32%

Profit Margin-52.59%

ROE-5.10%

ROA-4.60%

Growth

Revenue Growth88.30%

Earnings Growth—

Cash Flow & Leverage

Operating CF-2.37M $

CapEx (TTM)2.19M $

FCF Margin9.23%

FCF Yield3.33%

Net Debt-8.88M $

Net Debt/EBITDA0.80

Balance Sheet

Debt/Equity0.00

Current Ratio1.24

Quick Ratio0.65

Book Value/Sh1.948 USD

Cash/Share0.0540 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div DateFeb 27, 2023

Pay DateMar 6, 2023

Splits

Last Split1:5

Split DateJun 21, 2024

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.380.62M

Float133.30M

Insiders38.05%

Institutions0.10%

Short Interest

Short Ratio0.6d

Short % Float0.07%

Short % Out.0.05%

Shares Short209.18K

Short (prev mo.)178.28K

Technical

SMA 500.3172 (-17.3%)

SMA 2002.140 (-87.7%)

Beta—

S&P 52W Chg19.18%

Avg Vol (30d)22.43K

Avg Vol (10d)482.20K

Technical Indicators

RSI (14)39.5

MACD-0.0104

MACD Signal-0.0090

MACD Hist.-0.0014

BB Upper0.3099 USD

BB Middle0.2865 USD

BB Lower0.2631 USD

BB Width16.33%

ATR (14)0.0332 USD

Vol Ratio (20d)0.04x